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論文内容の要旨
Mycoplasmosis is one of the most important porcine
diseases. It has a great impact on the productivity and
the economic performance in swine industry world-
wide including Thailand where the pig production
system has been becoming more and more industrial-
ized. ‘Industrialized’ means ‘intensive management’
in which numerous pigs are reared in confined air
space. In these environments chronic diseases includ-
ing respiratory diseases, diarrhea and arthritis are
most common in every country. Recently catastrophic
disease called PRDC (porcine respiratory disease com-
plex) prevails all over the world. Among various eti-
ological agents which are claimed to be associated with
the disease Mycoplasma hyopneumoniae is considered
to play an essential role together with PRRS (porcine
reproductive and respiratory syndrome) virus. It not
only causes pneumonia (mycoplasmal pneumonia of
swine : MPS) by itself but also aggravates infections
caused by other agents especially PRRS virus infec-
tion, which escalates the economic losses induced by
PRDC. Mycoplasma hyosynoviae causes nonpurulent
polyarthritis in breeding and fattening pigs. The
disease is also prevailed all over the world. Little is
known on porcine mycoplasmas in Thailand because of
their difficulties of isolation and cultivation of the
organisms. The present investigations were carried
out to get information which will improve the diag-
nostic techniques of porcine mycoplasmosis and con-
tribute to the control of the diseases in that country.
In the first chapter antimicrobial susceptibilities ofM.
hyopneumoniae were investigated since it is an im-
portant etiological agent of not only MPS but also
PRDC. For isolates with resistance to macrolides, the
first choice drugs in chemotherapy for mycoplasmosis,
mechanisms of the resistance were examined by se-
quencing 23S rRNA of resistant isolates. In chapter 2
antimicrobial susceptibilities of M. hyosynoviae were
also investigated and in vitro development of macro-
lide and lincomycin resistance was examined to elu-
cidate the mechanisms of the resistance using type
strain S16 of this organism. Since early medication is
required for the effective chemotherapy of arthritis
due toM. hyosynoviae, rapid detection of this organism
was developed in chapter 3. Finally methods to see
the genetic diversity of field isolates ofM. hyosynoviae
in Thailand were evaluated from the perspective of
getting epidemiological information of the disease.
1. Antimicrobial susceptibilities ofMycoplasma
hyopneumoniae field isolates and occurrence of
enroflaxacin, macrolides and lincomycin resist-
ance
To assess the in vitro susceptibilities ofM. hyopneu-
moniae to antimicrobial agents is inevitable for the
chemotherapy of MPS. In this chapter a total of 159
Thai isolates of M. hyopneumoniae derived from
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pneumonic lungs of pigs in 41 farms during 2006-2011
were subjected for susceptibility testing against 12
antimicrobial agents widely used in Thailand ; chlor-
tetracycline (CTC), oxytetracycline (OTC), doxycycline
(DOXY), lincomycin (LCM), josamycin (JM), kitasamy-
cin (KT), spiramycin (SPM), tylosin (TS), erythromy-
cin (EM), tiamulin (TM), florfenicol (FFC) and en-
rofloxacin (ERFX). The type strain J of M. hyopneu-
moniae was also included in the test as the control
strain. Obtained data were compared with those for
27 isolates collected during 1997-1998.
Tiamulin showed the lowest minimal inhibitory
concentrations (MICs) among drugs tested ranged
between 0.013 and 0.2mg/ml and its MIC90 (MIC at
which 90% of the isolates tested were inhibited) was
0.1mg/ml. Next to TM, TS and LCM showed high
activities with MIC90 of 0.39mg/ml, however, two iso-
lates were resistant to these drugs showing a MIC
value of higher than 12.5mg/ml. Three macrolides,
SPM, JM and KT also showed high potency with
MIC90 of 0.78, 0.78 and 1.56mg/ml, respectively. Eryth-
romycin showed exceptionally low activity among five
macrolides tested with MIC50 of 50mg/ml. Florfenicol
showed moderately high activity with MIC90 of 1.56
mg/ml. Both OTC and DOXY showed similar activities
with FFC and their MIC range distributed from 0.39
to 12.5mg/ml with MIC90 of 6.25mg/ml. On the other
hand, activity of CTC to Thai isolates of M. hyopneu-
moniaewas low with MIC range from 3.12 to 100mg/ml,
MIC90 of 50mg/ml and MIC50 of 25mg/ml. The MICs of
ERFX distributed in a broad range from 0.1 to 25mg/ml
and those for 76 of 159 (47.7%) Thai isolates exceeded 2
mg/ml which is the breakpoint of this drug.
The comparison of susceptibilities of the present 159
isolates with those of isolates obtained from 1997 to
1998 in Thailand revealed that susceptibilities of the
present isolates to CTC, OTC, JM and TS were de-
creased considerably. The MIC90 for previous isolates
were 6.25, 0.78, 0.2 and 0.1, whereas those for present
isolates were 50, 6.25, 0.78 and 0.39mg/ml, respectively,
showing 4- to 8-fold higher MIC90. No change was ob-
served in MIC90 of LCM and TM between the present
isolates and the previous ones. The sequences of do-
main V of 23S rRNA of the two macrolides and LCM
resistant isolates were compared with those of M.
hyopneumoniae strain J and strain ATCC 27719 (Gen-
bank accession number AE017243 and X68421, respec-
tively). The result revealed a point mutation at
A2058G (E. coli coordinates) in both macrolides and
LCM resistant isolates.
2. Antimicrobial susceptibilities ofMycoplasma
hyosynoviae field isolates in Thailand during
2008-2011 and in vitro development of resistance
to tylosin and lincomycin in type strain S16 ofM.
hyosynoviae
No information is available on antimicrobial suscep-
tibilities of field isolates of M. hyosynoviae in Thai-
land. In this chapter 41 Thai isolates of M. hyosyno-
viae derived from tonsils (29), lungs (10) and joint
fluids (2) of pigs from 9 farms during 2008-2011 were
investigated for their in vitro susceptibilities against
10 antimicrobial agents widely used in Thailand,
namely OTC, DOXY, LCM, JM, KT, SPM, TS, TM,
FFC and ERFX. The type strain S16 ofM. hyosynoviae
was also included in the test. All isolates and type
strain S16 were examined for 23S rRNA transitions at
domain II and V which relate to macrolide resistance
and compared with MIC levels of macrolides and
lincomycin for each strain. In vitro development of
macrolides and lincomycin resistance in type strain
S16 of M. hyosynoviae were also investigated to
analyze the mechanisms of macrolides and lincomycin
resistance.
Of 10 antimicrobials tested, TM showed the lowest
MICs of 0.016-0.125mg/ml against all M . hyosynoviae
field isolates. Next to TM, LCM and JM showed high
activities with MIC90 of 1mg/ml. Both KT and FFC
showed moderately high activities with MIC90 of 2-4
mg/ml, whereas SPM and TS showed lower activities
with MIC90 of 8mg/ml. Activities of tetracyclines to
Thai isolates ofM. hyosynoviae were low and MICs for
OTC ranged from 16 to 128mg/ml and those for DOXY
from 4 to 16mg/ml. The MIC range of ERFX was
between 0.25 to 2mg/ml. Of the Thai isolates of M.
hyosynoviae considerable portion was resistant to
some of the drugs ; 41 of 41 for OTC (break point ; ≧16
mg/ml) , 15 of 41 (36.6%) for ERFX (≧2mg/ml) and 13 of
41 (31.7%) for TS (≧4mg/ml).
An acquired G745A transition in domain II was
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found in 13 isolates by sequence analysis of domain II
and V of 23S rRNA of all Thai isolates and type strain
S16 of M. hyosynoviae. The MICs of TS were of 4-8
mg/ml for these 13 isolates and 0.5-2.0mg/ml for re-
maining 28 isolates, suggesting strongly that this
G745A transition inM. hyosynoviae may confer a mild
resistance to TS. MIC values of other macrolides and
LCM were not correlated to this transition.
Type strain S16 of M. hyosynoviae was highly sus-
ceptible to both TS and LCM with the MICs of 0.032
and 0.125mg/ml respectively. In vitro development of
resistance to TS and LCM were investigated by pas-
saging this strain in broth medium containing various
concentrations of TS or LCM. At the first and second
passage, the highest concentration of TS and LCM
that allowed the growth of S16 was the same as that
for parent strain. From the third passage, the strain
began to get resistance to TS or LCM rapidly and could
grow at about 4 to 32 times higher concentrations in
each passage. At the sixth passage the highest con-
centration of the drug that S16 mutant strain could
grow was 4,000 or 1,000 times higher for TS or LCM
respectively. In LCM selection, the A2058C/G or
A2059C transitions were obtained in S16 mutants.
This mutant was resistant not only to LCM but also to
all macrolide drugs tested. In TS selection the A2062G
transition was obtained which conferred the resist-
ance to macrolides but not to LCM.
3. Development of semi-nested PCR for detec-
tion of 16S rRNA gene of Mycoplasma hyosyno-
viae
Successful treatment of arthritis due toM. hyosyno-
viae in pigs is best achieved by injecting effective
antimicrobials as early as possible. It needs several
days, however, to diagnose the disease since the iso-
lation of mycoplasmas is time-consuming. In this
chapter semi-nested PCR to detect M. hyosynoviae
using three oligonucleotide primers was developed for
the rapid diagnosis of the disease. The primers were
designed based on 16S rRNA gene of M. hyosynoviae
accession number U26730 from the three positions.
The position of a forward primer was at 196nt to 219nt
whereas the positions of an outer reverse primer and
an inner reverse primer were at 825nt to 844nt and
468nt to 491nt, respectively. The expected sizes of the
PCR products from the first and the second round of
the semi-nested PCR were 649bp and 295bp, respec-
tively. Using the adequate concentration of the M.
hyosynoviae DNA, the first round of semi-nested PCR
could generate an amplified fragment about 649bp
followed by an amplified fragment about 295bp for the
second round of semi-nested PCR. The specificity of
the test was examined with porcine mycoplasmal and
bacterial species commonly encountered in pneumonic
and/or arthritic lesions in pigs. The organisms tested
were as follows : Mycoplasma hyopneumoniae, M. hy-
orhinis, M. flocculare, M. arginini, M. bovigenitalium,
Arcanobacterium pyogenes, Actinobacillus pleuropneu-
moniae, Bordetella bronchiseptica, Escherichia coli,
Haemophilus parasuis, Klebsiella pneumoniae Pas-
teurella multocida Staphylococcus aureus and Strep-
tococcus suis. None of the primer pairs yielded PCR
products or non-specific bands with DNA from those
mycoplasmal and bacterial species. The semi-nested
PCR developed here detected as little as 10−14g of
purified M. hyosynoviae DNA in a reaction and the
limit of detection for clinical materials was at least
103 CFU (colony forming unit) per gram of the lung
samples. To evaluate the applicability of this method
a total of 300 tonsillar samples were collected at a
slaughterhouse and compared the detection rate with
that by cultivation. As a result 45 of 300 (15%) sam-
ples were positive by semi-nested PCR while 17 of 300
(5.7%) were positive by cultivation. Thus the semi-
nested PCR was shown to be a useful tool for rapid
detection ofM. hyosynoviae in clinical materials in pig
herds.
4. Genetic diversity ofMycoplasma hyosynoviae
field isolates in Thailand
It is essential to know the epidemiology of the dis-
ease such as source of infection or mode of transmis-
sion for the establishment of control measures for
arthritis due to M. hyosynoviae. Recently genetic het-
erogeneity of causal organisms has been widely util-
ized to get epidemiological information in various in-
fectious diseases. In this chapter genetic charac-
terization of field isolates of M. hyosynoviae was in-
vestigated by pulsed-field gel electrophoresis (PFGE)
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and random amplified polymorphic DNA (RAPD)
analyses. Mycoplasma hyosynoviae strains used were
the same as those in chapter 2. Well-separated DNA
fragments were obtained from 37 of 41 Thai isolates
and type strain S16 with PFGE. Four Thai isolates
did not yield clear bands. The banding patterns of the
typable strains consisted of 6-12 fragments in the size
range of 2-48kbp. Twenty-two different patterns were
detected among these strains. Among isolates derived
from the same farm, two to five different profiles were
also detected in addition to the same profiles. Though
different profiles were usually detected among isolates
derived from different farms, one common profile was
detected in two isolates from two different farms on an
occasion. These two farms were located in the same
province, suggesting ‘farm to farm’ transmission of
these isolates with the same profile. The PFGE tech-
nique had a high reproducibility with identical band-
ing patterns for replicate samples. Thus it revealed
that M. hyosynoviae had high genetic heterogeneity
both within a pig farm and among the farms by PFGE.
On the other hand it was suggested that PFGE might
be a useful tool for the epidemiological studies of M.
hyosynoviae infection from the fact that common pro-
file was detected in each isolate derived from different
farm in one occasion.
The RAPD analyses were carried out after various
preliminary experiments. The clear patterns were ob-
tained by using RAPD primer 6 and RAPD beads
(Ready-To-Go RAPD Analysis kit, GE healthcare, Life
Science, USA). The 41 Thai isolates and type strain
S16 were all typed with banding patterns consisting of
1-12 fragments in size range of 200-1,500bp. Thirty-
nine different patterns were detected among 42 strains
and two isolates with the same profile by PFGE
derived from different farms showed different pattern
by RAPD. On the other hand, the same banding pat-
terns were not necessarily obtained by repeated
analyses of the same strains. Due to this low repro-
ducibility RAPD analyses were not considered appro-
priate to obtain epidemiological information of the
disease despite its high discriminatory power.
The results on antimicrobial susceptibilities of M.
hyopneumoniae described in this work have great
importance for controlling not only MPS but also
PRDC in whichM. hyopneumoniae plays an important
role. Rapid detection of M. hyosynoviae enables the
rapid diagnosis and earlier medication of arthritis due
to M. hyosynoviae and improves the treatment to-
gether with the results of antimicrobial susceptibil-
ities. The elucidation of the mechanisms of macrolide
and LCM resistances ofM. hyosynoviae will contribute
to establish the prudent use of antimicrobials in ani-
mal husbandry. Lastly, PFGE analyses ofM. hyosyno-
viae isolates in Thailand will facilitate the molecular
epidemiological study of animal mycoplasmosis in that
country.
審査報告概要
マイコプラズマを原因とする肺炎や関節炎は養豚の生
産性を阻害する難治性疾病として重要である。本研究
は，肺炎起因菌であるMycoplasma hyopneumoniaeお
よび関節炎起因菌であるM. hyosynoviaeのタイ国分離
株には，マイコプラズマに対する第 1次選択薬であるマ
クロライド系薬剤のみならず，第 2次選択薬であるエン
ロフロキサシン耐性菌が増加していることを明らかにし
た。またマクロライド系薬剤に対する耐性機構は菌種に
より異なること，さらにM. hyosynoviaeでは抗菌剤の
存在により急激に耐性化することを明らかにした。これ
らの成績は，畜産領域における抗菌剤の慎重使用の確立
に貢献すると考えられる。またM. hyosynoviaeの迅速
検出法を考案したことは，本マイコプラズマによる関節
炎の早期診断と早期の薬剤投与を可能とし，薬剤感受性
成績とあいまって治療成績を向上させることができる。
さらにM. hyosynoviae分離株のパルスフィールド電気
泳動法による解析は，該菌の遺伝的多様性を明らかにす
るとともに，本方法が分子疫学調査に利用できることを
示した。
よって，審査員一同は博士（畜産学）の学位を授与す
る価値があると判断した。
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